ReviewCurrent oncology reports2022

Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class.

Jennifer A Marks et al.PubMed ↗Publisher ↗

No numbers read from the abstract.